Current status: 968 hESC lines, 5920 hiPSC lines, and 139 clinical studies, and 2175 certificates
Monthly statistic from Apr 1, 2024
Posted on April 1, 2024
| total lines | 6888 |
| hESC lines | 968 |
| hiPSC lines | 5920 |
| derivation countries | 46 |
| projects | 294 |
| providers | 889 |
| clinical studies | 139 |
| subclones | 2673 |
| certificates | 2175 |
| cell line certificates | 2032 |
| project certificates | 143 |